-
Physician Perspectives on Unmet Need and Treatment Options Among Patients With Relapsed Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) in Canada: Findings From Qualitative Interviews
Sep 9, 2025, 16:22 PM -
Impact Of Dupilumab Treatment On Healthcare Resource Utilization in Patients With Atopic Dermatitis in a Colombian Health Insurance Provider: An Observational Real-World Practice Study
Sep 9, 2025, 16:22 PM -
Leveraging Generative AI for Efficient Patient Safety Narrative Drafting: A Semaglutide Case Study
Sep 9, 2025, 16:22 PM -
Effectiveness of HPV Vaccination Across Europe: A Comparative Analysis
Sep 9, 2025, 16:22 PM -
Landscape Analysis of Initiatives to Improve Access to Orphan Drugs Led by Industry Patient and Academic Stakeholders
Sep 9, 2025, 16:22 PM -
Cost-Substitution and Hospital Diagnosis-Related Group (DRG) Performance Impact Analysis of Infliximab Biosimilar Adoption in Moderate-to-Severe Crohn's Disease Patients in China
Sep 9, 2025, 16:22 PM -
Insights From a French Postmarketing Authorization Early Access (MA EA) Mechanism: Projecting Clinical and Economic Benefits of Neoadjuvant Nivolumab–Platinum-Based Chemotherapy (PDC) in Resectable Non-Small Cell Lung Cancer
Sep 9, 2025, 16:22 PM -
Treatment Discontinuation in Idiopathic Pulmonary Fibrosis: A Systematic Review of Antifibrotic Drug Use and Tolerability
Sep 9, 2025, 16:22 PM -
Characterizing and Quantifying Impacts of Neuromyelitis Optica Spectrum Disorder (NMOSD) on Patients and Caregivers
Sep 9, 2025, 16:22 PM -
Thecosystem: A Systemwide Health and Social Care Decision Analytical Model to Assess Population-Based Interventions for Older People’s Care in the UK
Sep 9, 2025, 16:22 PM -
Cost Analysis of Polatuzumab Vedotin in Combination With Rituximab Cyclophosphamide Doxorubicin and Prednisone in the Treatment of Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma in Portugal
Sep 9, 2025, 16:22 PM -
Dominance in Economic Evaluation as a Leverage in Pharmaceutical Price Negotiation
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of CYP2C19 Genotype-Guided Antiplatelet Therapy for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention in the Netherlands
Sep 9, 2025, 16:22 PM -
Projected Rapid-Growing Economic Burden of Chronic Respiratory Multimorbidity in Singapore: Unveiling Diagnostic Gaps and Asian Phenotypes Through Health Administrative Data
Sep 9, 2025, 16:22 PM -
Assessing the Quality of Hemophilia Care: How Suitable Are Patient-Centered Outcomes to Compare Hospital Performance?
Sep 9, 2025, 16:22 PM -
Evaluation of Safety Signal Management in Europe: Insights From PRAC Reports (2016-2024)
Sep 9, 2025, 16:22 PM -
Estimating the Incidence and Prevalence of Menorrhagia in the UK Using the THIN Database
Sep 9, 2025, 16:22 PM -
Quantifying the Fiscal Value of Prevention Programs for Depression
Sep 9, 2025, 16:22 PM -
Budget Impact of a PreTRM-Guided Preventive Bundle for Preterm Birth in Low-Risk Pregnancies: A Microsimulation Study Using PRIME Trial Data
Sep 9, 2025, 16:22 PM -
Evaluating the Conceptual Structure of the Barriers to Preexposure Prophylaxis (PrEP) Access Survey: A Confirmatory Item Factor Analysis
Sep 9, 2025, 16:22 PM
